Raleigh Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
Other funds holding TFFP
Raleigh Capital Management's TFFP Position: Q4 2024 in Review
Raleigh Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 91 shares — an estimated $183 sold.
Raleigh Capital Management first reported a position in TFFP in Q2 2024 and held it in 2 quarters. The position peaked at $183 in Q3 2024. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Raleigh Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Raleigh Capital Management sold 91 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $183.
- Raleigh Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
- Raleigh Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $183 in Q3 2024.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Raleigh Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.